ProfileGDS5822 / ILMN_1248425
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 67% 70% 64% 69% 69% 72% 73% 69% 70% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 139.467
GSM1276600PDAC Late Ablation Control 253.270
GSM1276601PDAC Late Ablation Control 34464
GSM1276602PDAC Late Ablation 144.669
GSM1276603PDAC Late Ablation 251.469
GSM1276604PDAC Late Ablation 37072
GSM1303940PDAC Late Ablation_anti-CTLA4 163.673
GSM1303941PDAC Late Ablation_anti-CTLA4 26469
GSM1303942PDAC Late Ablation_anti-CTLA4 37170